We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$17.5B
AUM Growth
+$1.09B
Cap. Flow
+$196M
Cap. Flow %
1.12%
Top 10 Hldgs %
22.04%
Holding
1,814
New
115
Increased
670
Reduced
633
Closed
80

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$41.9M
2
DLB icon
Dolby
DLB
+$23M
3
TDOC icon
Teladoc Health
TDOC
+$20.9M
4
CPRT icon
Copart
CPRT
+$20.8M
5
DXCM icon
DexCom
DXCM
+$16M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Healthcare 17.89%
3 Financials 12.54%
4 Consumer Discretionary 10.12%
5 Industrials 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRMN
1076
Garmin
GRMN
$59.8B
$370K ﹤0.01%
4,634
-778
-14% -$63.7K
NOBL icon
1077
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$370K ﹤0.01%
10,658
+2,700
+34% +$91.9K
SPG icon
1078
Simon Property Group
SPG
$71.4B
$370K ﹤0.01%
2,314
-968
-29% -$167K
AMTD
1079
DELISTED
TD Ameritrade Holding Corp
AMTD
$366K ﹤0.01%
7,339
+1,141
+18% +$59.1K
AKBA icon
1080
Akebia Therapeutics
AKBA
$248M
$365K ﹤0.01%
75,401
NEAR icon
1081
iShares Short Maturity Bond ETF
NEAR
$4.88B
$364K ﹤0.01%
7,232
TVTY
1082
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$364K ﹤0.01%
22,150
-454
-2% -$8.76K
CSGS
1083
DELISTED
CSG Systems International
CSGS
$363K ﹤0.01%
7,434
-973
-12% -$44.5K
EZU icon
1084
iShare MSCI Eurozone ETF
EZU
$9.93B
$363K ﹤0.01%
9,168
-1,937
-17% -$76.3K
IMGN
1085
DELISTED
Immunogen Inc
IMGN
$362K ﹤0.01%
166,599
+91,692
+122% +$217K
BAC.PRL icon
1086
Bank of America Series L
BAC.PRL
$4.02B
$361K ﹤0.01%
263
+108
+70% +$144K
EDIT icon
1087
Editas Medicine
EDIT
$436M
$360K ﹤0.01%
14,533
HLI icon
1088
Houlihan Lokey
HLI
$8.63B
$357K ﹤0.01%
8,016
-630
-7% -$29.4K
XT icon
1089
iShares Future Exponential Technologies ETF
XT
$3.99B
$357K ﹤0.01%
9,252
AL
1090
DELISTED
Air Lease Corp
AL
$356K ﹤0.01%
+8,610
New +$328K
DES icon
1091
WisdomTree US SmallCap Dividend Fund
DES
$2.22B
$355K ﹤0.01%
13,098
+11
+0.1% +$301
AAXJ icon
1092
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.83B
$353K ﹤0.01%
5,065
-350
-6% -$24.3K
FFIN icon
1093
First Financial Bankshares
FFIN
$5.01B
$353K ﹤0.01%
11,476
-822
-7% -$24.7K
HDS
1094
DELISTED
HD Supply Holdings, Inc.
HDS
$353K ﹤0.01%
8,758
-13,447
-61% -$577K
CABO icon
1095
Cable One
CABO
$191M
$351K ﹤0.01%
300
COR icon
1096
Cencora
COR
$60B
$350K ﹤0.01%
4,104
-3,719
-48% -$294K
VIOO icon
1097
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.33B
$350K ﹤0.01%
4,906
+644
+15% +$45.5K
CODI icon
1098
Compass Diversified
CODI
$908M
$349K ﹤0.01%
+18,286
New +$312K
TCRT icon
1099
Alaunos Therapeutics
TCRT
$4.88M
$347K ﹤0.01%
397
-194
-33% -$133K
ABM icon
1100
ABM Industries
ABM
$2.84B
$342K ﹤0.01%
8,540
+40
+0.5% +$1.52K

Similar funds

William Blair & Company's Q2 2019 Portfolio in Review

As of Q2 2019, William Blair & Company held 1,814 positions worth $17.5B, up 6.6% from $16.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

William Blair & Company's Q2 2019 filing shows 115 new, 670 increased, 633 reduced and 80 closed positions. Its largest new stake was Q2 Holdings: 213,468 shares worth $16.3M. The largest sale was Red Hat Inc, an estimated $144M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2019 buy was Q2 Holdings: 213,468 shares worth $16.3M.
  • William Blair & Company added most to Fiserv Inc in Q2 2019, an estimated $41.9M increase.
  • William Blair & Company's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $16.4M.
  • William Blair & Company fully exited Red Hat Inc in Q2 2019, selling an estimated $144M.
  • William Blair & Company's ten largest holdings make up 22% of its $17.5B portfolio in Q2 2019.
  • William Blair & Company opened 115 new positions and closed 80 in Q2 2019.
  • William Blair & Company's portfolio value rose 6.6% quarter-over-quarter to $17.5B.

Based on William Blair & Company's 13F filing for Q2 2019, filed 13 Aug 2019.